ViiV Healthcare Company
$38.7M 65,891 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Exelixis Inc.
Exelixis Inc. reported $37,105,515.74 across General Payments, Research, and Ownership to 10,612 physicians and teaching hospitals across 16,351 transactions.
- $37.1M
- All-tracks total
- 16,351
- Transactions
- 10,612
- Recipients
- +$148.4K
- General Payments vs PY2023
Exelixis Inc. reported $37,105,515.74 across all CMS Open Payments tracks (General + Research + Ownership) to 10,612 physicians and teaching hospitals in Program Year 2024 - ranking #60 of 1,925 reporting manufacturers (0.3% of the all-tracks industry total); General Payments alone were $4,045,027.21, averaging $3.5K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer exelixis-inc Exelixis Inc.
$37.1M · #60/1,925 · 0.3% industry · PY2024
- TOT $37.1M
- RANK #60
- SHARE 0.3%
- TXN 16,351
- RCP 10,612
- CAT 10
- GEN $4.0M
- ΔGEN +$148.4K
- TOP1 21.4%
- PY 2024
Volume peers
Nearest volume peer: ViiV Healthcare Company ($38.7M)
Exelixis Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Exelixis Inc.'s CMS-reported General Payments increased by $148.4K (+3.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: EXELIXIS INC.PY2023: EXELIXIS INC.PY2024: Exelixis Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $3,896,585.70
- PY2024
- $4,045,027.21
What the Data Shows for Exelixis Inc.
Rank #60 of 1,925 companies in CMS Open Payments for 2024 belongs to Exelixis Inc., which reported $37,105,515.74 across 16,351 transactions to 10,612 recipients - representing 0.3% of all industry payments reported nationwide for the year. Averages work out to $2.3K per transaction and $3.5K per recipient.
26 transactions worth $1.3M make "Compensation for Services Other Than Consulting" the top general-payment category in the 10-category breakdown below, 32.5% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Compensation for Services Other Than Consulting" leads Exelixis Inc.'s 10-category general-payment breakdown at $1.3M, 32.5% of the reported total.
Exelixis Inc. reports 10 general-payment categories - the top three are Compensation for Services Other Than Consulting (32.5%), Consulting Fee (21.3%), and Compensation for Faculty or Speaker (Medical Education) (16.8%). The remaining 7 categories make up 29.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Exelixis Inc. files across 10 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Exelixis Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $1.3M | 26 | 32.5% |
| Consulting Fee | $862.5K | 84 | 21.3% |
| Compensation for Faculty or Speaker (Medical Education) | $679.9K | 246 | 16.8% |
| Honoraria | $353.6K | 164 | 8.7% |
| Travel and Lodging | $325.6K | 1,287 | 8.0% |
| Food and Beverage | $274.0K | 8,466 | 6.8% |
| Space Rental or Facility Fees | $175.6K | 27 | 4.3% |
| Charitable Contribution | $28.5K | 4 | 0.7% |
| Education | $26.3K | 307 | 0.7% |
| Grant | $5.0K | 1 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,973,064.94 (48.8%) of $4,045,027.21 in this company's General Payments records across 4,087 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Exelixis Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Denver Health Medical Center
$867,340.14 across 19 reported transactions
- 2
Stephen Saletan
$520,425.92 across 51 reported transactions
- 3
Sue Eckhardt
$382,050.49 across 26 reported transactions
- 4
Alan Garber
$123,248.39 across 6 reported transactions
- 5
Stephen Sherwin
$80,000.00 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Exelixis Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Exelixis Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Exelixis Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Alnylam Pharmaceuticals Inc.
$39.2M 19,104 recipients
Compare payment profiles
Alexion Pharmaceuticals, Inc.
$34.7M 48,499 recipients
Compare payment profiles
Kite Pharma, Inc.
$34.1M 2,852 recipients
Compare payment profiles
Braintree Laboratories, Inc.
$33.9M 5,369 recipients
Compare payment profiles
Mirati Therapeutics, Inc.
$33.7M 4,888 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.